| Literature DB >> 22829748 |
Amir Houshang Mohammad Alizadeh1, Esmaeil Shamsi Afzali, Anahita Shahnazi, Azare Sanati, Dariush Mirsattari, Mohammad Reza Zali.
Abstract
Background. The present study sought and compared the utility and safety of endoscopic retrograde cholangiopancreatography (ERCP) in the elderly and younger people in a great sample of Iranian population. Methods. Our study involved 780 patients undergoing diagnostic and therapeutic ERCP at the Taleghani hospital in Tehran between 2010 and 2011; among them, 558 patients were less than 70 years old and others were 70 years old or older. The patients were prospectively identified and data including clinical and biochemical features, ERCP procedures, ERCP diagnosis, and ERCP complications were gathered on them prospectively. Results. Clinical manifestations were comparable in young and older groups except for hepatosplenomegaly and constipation that were more prevalent in the elderly. Laboratory findings were similar in both groups other than mean levels of alkaline phosphatase, hemoglobin and albumin levels, which were higher in the elderly group. Selective biliary cannulation was technically more successful in the younger than in others (89.0% versus 81.8%). Common bile duct stone was the most frequent diagnosis in both young and older groups (36.6% and 45.9%, resp.), whereas ERCP was reported to be normal in 13.4% of the younger and 5.0% of the elderly patients. Post-ERCP complications were observed in 4.8% of patients aged less than 70 years in comparison with 2.3% of patients aged over 70 years. The most frequent complication was pancreatitis that was significantly more developed in young than older patients (3.6% versus 1.5%; OR: 8.216, P = 0.015). Conclusion. Diagnostic ERCP is safe and well tolerated in the elderly and even associated with significantly less risk than the younger.Entities:
Year: 2012 PMID: 22829748 PMCID: PMC3399376 DOI: 10.1155/2012/439320
Source DB: PubMed Journal: Diagn Ther Endosc ISSN: 1026-714X
Baseline characteristics and medical history in the group aged less than 70 years in comparison with the elderly.
| Characteristics | Group < 70 years old ( | Group ≥ 70 years old ( |
|
|---|---|---|---|
| Male gender | 270 (48.4) | 123 (55.7) | 0.067 |
| Age (years) | 49.6 ± 14.0 | 76.3 ± 5.0 | <0.001 |
| Medical history: | |||
| Diabetes mellitus | 69 (12.4) | 20 (9.0) | 0.183 |
| Hypertension | 78 (14.0) | 63 (28.4) | <0.001 |
| Coronary artery disease | 32 (5.7) | 31 (14.0) | <0.001 |
| Cholecystectomy | 207 (37.1) | 76 (34.2) | 0.453 |
| Previous ERCP | 51 (9.1) | 19 (8.6) | 0.798 |
| Biliary stone | 56 (10.0) | 24 (10.8) | 0.748 |
| Cirrhosis | 8 (1.4) | 3 (1.4) | 0.999 |
| Pancreatitis | 24 (4.3) | 3 (1.4) | 0.042 |
| Cigarette smoking | 66 (11.8) | 31 (14.0) | 0.415 |
| Alcohol use | 17 (3.0) | 5 (2.3) | 0.545 |
| Opium addiction | 29 (5.2) | 13 (5.9) | 0.713 |
Data are presented as mean ± SD or n (%).
Clinical manifestations in the group aged less than 70 years in comparison with the elderly.
| Manifestations | Group < 70 years old ( | Group ≥ 70 years old ( |
|
|---|---|---|---|
| Fever | 25 (4.5) | 15 (6.8) | 0.193 |
| Weight loss | 165 (29.6) | 78 (35.1) | 0.130 |
| Anorexia | 136 (24.4) | 57 (25.7) | 0.704 |
| Fatigue | 40 (7.2) | 25 (11.3) | 0.062 |
| Icterus | 267 (47.8) | 102 (45.9) | 0.631 |
| hepatosplenomegaly | 9 (1.6) | 10 (4.5) | 0.018 |
| Dark urine | 152 (27.2) | 58 (26.1) | 0.752 |
| Diarrhea | 5 (0.9) | 5 (2.3) | 0.158 |
| Constipation | 39 (7.0) | 27 (12.2) | 0.019 |
Data are presented as n (%).
Pre-ERCP laboratory parameters in the group aged less than 70 years in comparison with the elderly.
| Laboratory parameters | Group < 70 years old ( | Group ≥ 70 years old ( |
|
|---|---|---|---|
| Hemoglobin | 12.0 ± 1.8 | 11.6 ± 1.7 | 0.030 |
| Albumin | 4.0 ± 0.6 | 3.7 ± 0.6 | <0.001 |
| ESR | 31.7 ± 18.4 | 32.1 ± 18.7 | 0.776 |
| AST | 85.5 ± 95.1 | 86.3 ± 80.6 | 0.907 |
| ALT | 103.5 ± 114.5 | 125.9 ± 330.7 | 0.338 |
| ALP | 784.1 ± 750.1 | 919.0 ± 888.9 | 0.038 |
| Lactate dehydrogenase | 472.3 ± 361.0 | 444.7 ± 225.6 | 0.364 |
| Total bilirubin | 6.4 ± 8.8 | 6.5 ± 9.0 | 0.815 |
| Direct bilirubin | 3.5 ± 5.1 | 3.7 ± 5.3 | 0.640 |
| Serum baseline amylase | 160.1 ± 345.5 | 190.1 ± 365.2 | 0.402 |
Data are presented as mean ± SD.
Figure 1